Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 11:57 ET | Source: Bragar Eagel & Squire

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
January 05, 2026 16:51 ET | Source: Bragar Eagel & Squire

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

According to the lawsuit, Telix overstated prostate cancer drug progress and supply-chain quality, making its public statements misleading.
January 02, 2026 10:03 ET | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
December 19, 2025 09:43 ET | Source: Faruqi & Faruqi LLP

TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or...
December 18, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 15, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 11, 2025 17:41 ET | Source: Bragar Eagel & Squire

TELIX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

The lawsuit alleges Telix overstated progress on its prostate cancer candidates and supply-chain strength, making its public statements misleading.
December 11, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 08, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.
December 04, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Telix Pharmaceuticals Limited investors that lost money are encouraged to contact BG&G before the January 9, 2026 lead plaintiff deadline.